BRIEF published on 08/08/2024 at 07:35, 1 year 7 months ago Evotec Advances Neuroscience Partnership with Bristol Myers Squibb Partnership Research Neuroscience Evotec Bristol Myers Squibb
PRESS RELEASE published on 08/08/2024 at 07:30, 1 year 7 months ago Evotec announces progress in strategic neuroscience partnership with Bristol Myers Squibb Evotec SE announces progress in strategic neuroscience partnership with Bristol Myers Squibb, receiving US$ 25 million payment for further research on neurodegenerative diseases Evotec SE Research Neurodegenerative Diseases Bristol Myers Squibb Neuroscience Partnership
BRIEF published on 08/07/2024 at 13:05, 1 year 7 months ago Evotec SE to Announce First Half-Year 2024 Results on 14 August 2024 Financial Results Conference Call Evotec SE Webcast First Half-year 2024
PRESS RELEASE published on 08/07/2024 at 13:00, 1 year 7 months ago Evotec SE reports first half-year 2024 results on 14 August 2024 Evotec SE to report first half-year 2024 results on 14 August 2024. Conference call scheduled to discuss financial performance and updates. Webcast available on www.evotec.com/en/investor-relations/financial-publications Conference Call Financial Performance Evotec SE Webcast First Half-year Results
BRIEF published on 08/06/2024 at 21:12, 1 year 7 months ago Evotec Provides Updated Fiscal Guidance for 2024 Adjusted EBITDA Revenue Forecast Sustainable Growth 2024 Guidance Evotec
BRIEF published on 08/06/2024 at 21:09, 1 year 7 months ago Evotec SE Updates Financial Guidance for 2024 Adjusted EBITDA Revenue Forecast Financial Guidance Evotec SE R&D Expenditure
PRESS RELEASE published on 08/06/2024 at 21:07, 1 year 7 months ago Evotec provides guidance update Evotec SE refines guidance for fiscal year 2024, expecting moderate revenue growth, reduced R&D expenditures, and adjusted EBITDA; aims for sustainable profitable growth amid market challenges Adjusted EBITDA Revenue Growth Evotec SE Guidance Update R&D Expenditures
PRESS RELEASE published on 08/06/2024 at 21:04, 1 year 7 months ago EQS-Adhoc: Evotec SE provides guidance update Evotec SE refines guidance for fiscal year 2024, expecting revenue and EBITDA adjustments due to slower sales conversion and margin pressures, focusing on sustainable growth EBITDA Revenue Evotec SE Sustainable Growth Guidance Update
BRIEF published on 07/10/2024 at 07:35, 1 year 8 months ago Evotec and Pfizer Collaborate to Advance Drug Discovery in France Drug Discovery Metabolic Diseases Evotec Pfizer Infectious Diseases
PRESS RELEASE published on 07/10/2024 at 07:30, 1 year 8 months ago Evotec and Pfizer collaborate to advance drug discovery in France Evotec SE collaborates with Pfizer to focus on early discovery research for metabolic and infectious diseases in France. The multi-year agreement includes research support and potential milestones Drug Discovery Evotec SE France Pfizer Metabolic And Infectious Diseases
Published on 03/17/2026 at 08:20, 1 hour 15 minutes ago Nano One Advances Candiac LFP Production Capacity Expansion Project, Detailed Engineering & Equipment Procurement
Published on 03/17/2026 at 08:05, 1 hour 30 minutes ago BioNxt Signs Strategic Agreement for Eurasian Commercialization Following Cladribine ODF Patent Grant in Eurasia and Europe
Published on 03/17/2026 at 08:01, 1 hour 34 minutes ago Star Copper Reports First Phase 2 Drill Results Extending Mineralization to West, North and South
Published on 03/16/2026 at 22:30, 11 hours 5 minutes ago Core Silver Intersects High-Grade Copper-Molybdenum Veins up to 7.31% Cu & 1.01% Mo Confirming Large Porphyry System at Laverdiere
Published on 03/17/2026 at 09:20, 15 minutes ago Le Clarence Awarded Two Michelin Stars Under the Direction of Andrea Capasso
Published on 03/17/2026 at 09:05, 30 minutes ago Mintos broadens its offering with regulated crypto ETPs in collaboration with Upvest
Published on 03/17/2026 at 09:05, 30 minutes ago THE SEVEN DEADLY SINS: ORIGIN NOW AVAILABLE TO PLAY EARLIER ON PLAYSTATION®5 AND STEAM
Published on 03/17/2026 at 09:02, 32 minutes ago Turkiye Garanti Bankasi A.S.: Regarding the Sale of Non-Performing Loans Portfolio
Published on 03/17/2026 at 09:01, 34 minutes ago Original-Research: Power Metallic Mines Inc. (von GBC AG): BUY
Published on 03/17/2026 at 07:00, 2 hours 35 minutes ago Invitation to the Extraordinary General Meeting of shareholders
Published on 03/16/2026 at 18:00, 15 hours 35 minutes ago Disclosure of trading in own shares from 09/03/2026 to 13/03/2026
Published on 03/16/2026 at 17:58, 15 hours 37 minutes ago Aéroports de Paris S.A - February 2026 traffic figures
Published on 03/16/2026 at 17:56, 15 hours 38 minutes ago Reporting on share buyback transactions carried out between March 9 and March 13, 2026
